Search

Your search keyword '"Veersema D"' showing total 18 results
Start Over Author "Veersema D"
18 results on '"Veersema D"'

1. Echo hoort in basispakket

Author

Pajkrt, E., Veersema, D., Haak, M. C., Amsterdam Public Health, Amsterdam Reproduction & Development, and Obstetrics and Gynaecology

Published
2011

2. Contributors

Author

Abels, T, primary, Abu-Osba, Y K, additional, Ahmad, M S, additional, Al-Habbal, A M, additional, Albin, N A, additional, Alexander, D P, additional, Alexander, S, additional, Alverson, D C, additional, Andrews, D C, additional, Antila, K J, additional, Arnold, J M, additional, Bekedam, D J, additional, Benthin, M, additional, Berec, A, additional, Berman, W, additional, Bernard, N, additional, Blomquist, T, additional, Britton, H G, additional, Burns, P N, additional, Cantraine, F, additional, Carter, M C, additional, Castle, B, additional, Cooper, M, additional, Dahl, P, additional, Dawes, G S, additional, Dawson, A J, additional, De Bakker, O, additional, De Toffoli Konishi, G, additional, Dillon, T, additional, Dodgson, M S, additional, Doyle, A T, additional, Dunn, P M, additional, Eldridge, M, additional, Elzouki, A, additional, Eriksen, P S, additional, Evans, J M, additional, Fallenstein, F, additional, Faquih, A, additional, Fazary, A L, additional, Gennser, G, additional, Gill, R W, additional, Gough, N A J, additional, Grella, P, additional, Martino, V, additional, Hoogland, H J, additional, Huch, A, additional, Huch, R, additional, Jansen, T C, additional, Jensen, O, additional, Johnson, P, additional, Jorgensen, N-P, additional, Kariniemi, V, additional, Kishan, J, additional, Kuzniar, J, additional, Leblanc, R, additional, Lindstrom, K, additional, Lingman, G, additional, Lubbers, D W, additional, Maarof, H M, additional, Mackenzie Nuffield, I Z, additional, Magne, P H, additional, Marsal, K, additional, Martino, R, additional, Melchior, J, additional, Mir, N A, additional, Morgenstern, J, additional, Murrills Wessex Regional, A J, additional, Nagel, J H, additional, Naumann, U, additional, Nickelsen, C, additional, Niermeijer, M F, additional, Oja, R T, additional, Parsons, R J, additional, Piela, A, additional, Redman, Nuffield, C W G, additional, Redstone, D, additional, Rolfe, P, additional, Ryan, G D, additional, Sa'di, A R, additional, Schettler, H, additional, Schmidt, S, additional, Schwers, J, additional, Sharp, F, additional, Sheddon, J, additional, Siimes, A S I, additional, Skret, A, additional, Smith, N C, additional, Somville, T, additional, Soni, A, additional, Southall, D P, additional, Soutter, W P, additional, Spencer, J A D, additional, Stewart, P A, additional, Svenningsen, L, additional, Szmigiel, Z, additional, Talbert, D G, additional, Thalji, A A, additional, Thomsen, S G, additional, Tonge, H M, additional, Uttendorfsky, O Th, additional, Valimaki, I A, additional, Van der Wiel, A R, additional, Veersema, D, additional, Velussi, C, additional, Verhoeff, A, additional, Vetter, K, additional, Visser, G H A, additional, Vossen, M, additional, Wallenburg, H C S, additional, Weber, T, additional, Wheeler, T, additional, Wilmshurst, T H, additional, Wladmiroff, J W, additional, Wolf Biomedical, P, additional, Wollner, J C, additional, Wolton, R S, additional, and Zaczek, T, additional

Published
1986
Full Text
View/download PDF

4. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study.

Author

Os, M.A. van, Ven, J.A. van der, Kleinrouweler, C.E., Pajkrt, E., Miranda, E. de, Wassenaer, A. van, Porath, M., Bossuyt, P.M., Bloemenkamp, K.W., Willekes, C., Woiski, M.D., Oudijk, M.A., Bilardo, K.M., Sikkema, M.J., Duvekot, J.J., Veersema, D., Laudy, J., Kuiper, P., Groot, C.J. de, Mol, B.W., Haak, M.C., Os, M.A. van, Ven, J.A. van der, Kleinrouweler, C.E., Pajkrt, E., Miranda, E. de, Wassenaer, A. van, Porath, M., Bossuyt, P.M., Bloemenkamp, K.W., Willekes, C., Woiski, M.D., Oudijk, M.A., Bilardo, K.M., Sikkema, M.J., Duvekot, J.J., Veersema, D., Laudy, J., Kuiper, P., Groot, C.J. de, Mol, B.W., and Haak, M.C.

Abstract

Contains fulltext : 97255.pdf (postprint version ) (Open Access), BACKGROUND: Women with a short cervical length in mid-trimester pregnancy have a higher risk of preterm birth and therefore a higher rate of neonatal mortality and morbidity. Progesterone can potentially decrease the number of preterm births and lower neonatal mortality and morbidity. Previous studies showed good results of progesterone in women with either a history of preterm birth or a short cervix. However, it is unknown whether screening for a short cervix and subsequent treatment in mid trimester pregnancy is effective in low risk women. METHODS/DESIGN: We plan a combined screen and treat study among women with a singleton pregnancy without a previous preterm birth. In these women, we will measure cervical length at the standard anomaly scan performed between 18 and 22 weeks. Women with cervical length

Published
2011

5. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study

Author

van Os, MA, van der Ven, JA, Kleinrouweler, CE, Pajkrt, E, de Miranda, E, van Wassenaer, A, Porath, M, Bossuyt, PM, Bloemenkamp, KWM, Willekes, C, Woiski, M, Oudijk, MA, Bilardo, KM, Sikkema, MJ, Duvekot, J.J., Veersema, D, Laudy, JAM, Kuiper, Ronella, de Groot, CJA, Mol, BWJ (Ben), Haak, MC, van Os, MA, van der Ven, JA, Kleinrouweler, CE, Pajkrt, E, de Miranda, E, van Wassenaer, A, Porath, M, Bossuyt, PM, Bloemenkamp, KWM, Willekes, C, Woiski, M, Oudijk, MA, Bilardo, KM, Sikkema, MJ, Duvekot, J.J., Veersema, D, Laudy, JAM, Kuiper, Ronella, de Groot, CJA, Mol, BWJ (Ben), and Haak, MC

Abstract

Background: Women with a short cervical length in mid-trimester pregnancy have a higher risk of preterm birth and therefore a higher rate of neonatal mortality and morbidity. Progesterone can potentially decrease the number of preterm births and lower neonatal mortality and morbidity. Previous studies showed good results of progesterone in women with either a history of preterm birth or a short cervix. However, it is unknown whether screening for a short cervix and subsequent treatment in mid trimester pregnancy is effective in low risk women. Methods/Design: We plan a combined screen and treat study among women with a singleton pregnancy without a previous preterm birth. In these women, we will measure cervical length at the standard anomaly scan performed between 18 and 22 weeks. Women with cervical length <= 30 mm at two independent measurements will be randomly allocated to receive either vaginal progesterone tablets or placebo between 22 and 34 weeks. The primary outcome of this trial is adverse neonatal condition, defined as a composite outcome of neonatal mortality and severe morbidity. Secondary outcomes are time to delivery, preterm birth rate before 32, 34 and 37 weeks, days of admission in neonatal intensive care unit, maternal morbidity, maternal admission days for preterm labour and costs. We will assess growth, physical condition and neurodevelopmental outcome of the children at two years of age. Discussion: This study will provide evidence for the usefulness and cost-effectiveness of screening for short cervical length at the 18-22 weeks and subsequent progesterone treatment among low risk women.

Published
2011

9. Pregnancy Following Transcervical Transfer of Oocyte and Sperm

Author

Bernardus Re, Veersema S, Schoemaker J, Veersema D, and J. P. W. Vermeiden

Subjects
Male, Pregnancy, business.industry, Cervix Uteri, General Medicine, Oocyte, medicine.disease, Sperm, Andrology, Reproductive Techniques, medicine.anatomical_structure, medicine, Humans, Female, business
Published
1989
Full Text
View/download PDF

10. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study

Author

Duvekot Johannes J, Sikkema Marko J, Bilardo Katia M, Oudijk Martijn A, Woiski Mallory, Willekes Christine, Bloemenkamp Kitty WM, Bossuyt Patrick M, Porath Martina, van Wassenaer Aleid, de Miranda Esteriek, Pajkrt Eva, Kleinrouweler C, van der Ven Jeanine A, van Os Melanie A, Veersema Diederik, Laudy Jacqueline, Kuiper Petra, de Groot Christianne JM, Mol Ben Willem J, and Haak Monique C

Subjects
Gynecology and obstetrics, RG1-991
Abstract

Abstract Background Women with a short cervical length in mid-trimester pregnancy have a higher risk of preterm birth and therefore a higher rate of neonatal mortality and morbidity. Progesterone can potentially decrease the number of preterm births and lower neonatal mortality and morbidity. Previous studies showed good results of progesterone in women with either a history of preterm birth or a short cervix. However, it is unknown whether screening for a short cervix and subsequent treatment in mid trimester pregnancy is effective in low risk women. Methods/Design We plan a combined screen and treat study among women with a singleton pregnancy without a previous preterm birth. In these women, we will measure cervical length at the standard anomaly scan performed between 18 and 22 weeks. Women with cervical length ≤ 30 mm at two independent measurements will be randomly allocated to receive either vaginal progesterone tablets or placebo between 22 and 34 weeks. The primary outcome of this trial is adverse neonatal condition, defined as a composite outcome of neonatal mortality and severe morbidity. Secondary outcomes are time to delivery, preterm birth rate before 32, 34 and 37 weeks, days of admission in neonatal intensive care unit, maternal morbidity, maternal admission days for preterm labour and costs. We will assess growth, physical condition and neurodevelopmental outcome of the children at two years of age. Discussion This study will provide evidence for the usefulness and cost-effectiveness of screening for short cervical length at the 18-22 weeks and subsequent progesterone treatment among low risk women. Trial registration Netherlands Trial Register (NTR): NTR207

Published
2011
Full Text
View/download PDF

14. Decision making in prenatal screening: money matters.

Author

Verweij EJ, Veersema D, Pajkrt E, and Haak MC

Subjects
Adult, Costs and Cost Analysis, Counseling, Female, Humans, Pilot Projects, Pregnancy, Pregnancy Trimester, First, Ultrasonography, Prenatal economics, Decision Making, Prenatal Diagnosis economics
Abstract

The aim of this study is to determine the influence of withdrawal of reimbursement on the uptake of the first-trimester combined test. Until January 2007 the combined test was offered to all pregnant women in a designated geographical area as a pilot study before the introduction of the national screening program in the Netherlands, to test the logistic procedures. In January 2007 the insurance companies suddenly stopped paying for the combined test with respect to women aged ≤35 years by decision of the government. In 2006 the combined test was performed in 4616 women compared with 3459 who had the combined test in 2007, a reduction of 25% (95% CI 23.8-26.3%, p < 0.001). A decline was observed in the uptake of the combined test in women aged ≤35 years (p < 0.001) as opposed to an increase in uptake in women aged ≥36 years (p < 0.001). The financial impact on the uptake of the first-trimester combined test should not be underestimated., (© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.)

Published
2015
Full Text
View/download PDF

15. [Pregnancy in older allochthonous women].

Author

Govaerts LC, Veersema D, and Keyzer J

Subjects
Adult, Female, Humans, Middle Aged, Pamphlets, Patient Education as Topic, Pregnancy, Pregnancy Complications ethnology
Published
1996

Catalog

Books, media, physical & digital resources
See catalog results